Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/20/2003DE20121966U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
11/20/2003CA2823041A1 Fgf variants and methods for use thereof
11/20/2003CA2775017A1 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism
11/20/2003CA2523888A1 Transgenic rat and the use thereof in the animal model for human huntingdon's disease and nuclear constructs, vectors and cells for the production thereof
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2487236A1 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003CA2485439A1 Anth1 chimeric antagonist
11/20/2003CA2485437A1 Peptide compounds and their use as protease substrates
11/20/2003CA2485365A1 Ctp-extended erythropoietin
11/20/2003CA2485363A1 Ferritin fusion proteins for use in vaccines and other applications
11/20/2003CA2485138A1 Androgen-regulated pmepa1 gene and methods of using the same to inhibit cancer cell growth
11/20/2003CA2485119A1 Promoters with modified transcription efficiency
11/20/2003CA2484845A1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003CA2484704A1 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003CA2484669A1 Brachyspira hyodysenteriae vaccine
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484279A1 Improved polysaccharide and glycoconjugate vaccines
11/20/2003CA2484211A1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2483698A1 Cytokine polypeptides
11/20/2003CA2483602A1 Fgf variants and methods for use thereof
11/20/2003CA2483025A1 Mammalian genes modulated during fasting and feeding
11/20/2003CA2482690A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein
11/19/2003EP1362918A1 Gene transfer methods
11/19/2003EP1362917A2 A fusion protein for use as vector
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362910A1 Lectins for analyzing sugar chains and method of using the same
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362867A2 Control of the ratio of LAP to LIP
11/19/2003EP1362866A1 Use of the repressor glxR for the synthesis of lysine in Corynebacterium glutamicum
11/19/2003EP1362601A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362595A1 Stable fibrinogen solution
11/19/2003EP1362510A2 A mouse model for hepatocellular carcinoma by targeted integration of hepatitis B virus genes
11/19/2003EP1362127A2 Serpin drugs for treatment of hiv infection and method of use thereof
11/19/2003EP1362125A2 Method for identifying biologically active structures of microbial pathogens
11/19/2003EP1362113A2 Constitutive promoter from arabidopsis
11/19/2003EP1362112A2 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
11/19/2003EP1362111A2 Regulatory genes suitable for use in gene expression
11/19/2003EP1362110A1 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
11/19/2003EP1362109A2 Recombinant oligomeric protein complexes with enhanced immunogenic potential
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362103A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/19/2003EP1362102A1 Pg-3 and biallelic markers thereof
11/19/2003EP1362100A2 Novel p53-inducible protein
11/19/2003EP1362098A2 Thioredoxin derived from h. pylori, which is cabable of inhibiting nf-kappa b activation
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362059A2 Method for identifying herbicidally active substances
11/19/2003EP1362058A2 Comparative ligand mapping from mhc positive cells
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361886A2 Methods and compositions for inhibiting hiv-coreceptor interactions
11/19/2003EP1361883A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam6, expressed highly in the small intestine
11/19/2003EP1240350A4 P2y12 receptor
11/19/2003EP1140150B1 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
11/19/2003EP1047446B1 Vaccine composition for herpes simplex virus and methods of using
11/19/2003EP1011723B1 88kda tumorigenic growth factor and antagonists
11/19/2003EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0756449B1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003EP0724634B1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
11/19/2003EP0640137B1 Immortalized human cell lines containing exogenous cytochrome p450 genes
11/19/2003CN1457366A Method to detect modulators of VEGF kinase domain
11/19/2003CN1457363A Hypersensitive response eliciting domains of bacterial harpin and use thereof
11/19/2003CN1457340A Petrides and derivatives thereof showing cell attachment, spreading and detachment activity
11/19/2003CN1457258A Methods of treating viral diseases with IL-18 and IL-18 compositions
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456574A Preparing method for extracting polypeptide antibiotics from silkworm
11/19/2003CN1456573A Nacre substrate protein, coding gene and cloning method and application thereof
11/19/2003CN1128222C Novel secretion expression vector and its application of recombinant hirudin expression technology
11/19/2003CN1128155C Colored mistletoe herb goycoprotein extraction and its medicine composite and preparation
11/18/2003US6649813 Induction of resistance to virus diseases by transformation of plants with a plant virus replicase gene
11/18/2003US6649769 For labelling a polynucleotides
11/18/2003US6649751 Reacting biopolymers with alkylamines and ammonium hydroxide, heating and eluting through columns having ion exchange resins, then recovering the polynuleotides; solid phase synthesis
11/18/2003US6649747 Composition and method for diagnosing auto-immune hepatitis
11/18/2003US6649746 Isolated nucleotide sequence encoding a peptide comprising a protease cleavage site; rehydration due to diarrhea and nutrition therapy
11/18/2003US6649744 Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649739 Protein, its gene, reagents for inducing apoptosis, and anticancer agent
11/18/2003US6649738 Pancreas-derived plasminogen activator inhibitor
11/18/2003US6649735 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
11/18/2003US6649595 FK506 binding proteins (FKBPs); rapamysin derivatives; multimerizing chimeric proteins in genetically engineered cells using said derivatives
11/18/2003US6649591 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury
11/18/2003US6649588 Using ebaf protein from amino acid sequence 2
11/18/2003US6649409 Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs
11/18/2003US6649407 Viral fiber protein for use in the treatment of viral diseases
11/18/2003US6649396 Fiber receptor-independent system for the propagation of adenoviral vectors
11/18/2003US6649393 Mutant form of cytotoxic ribonucleolytic protein which allows production by recombinant methods
11/18/2003US6649392 Mutant form of a cytotoxic ribonucleolytic protein which allows production by recombinant methods
11/18/2003US6649387 Enzymatic oxidative deamination process
11/18/2003US6649385 Isolated nucleic acid molecules encoding human squalene synthase proteins, and related products and processes
11/18/2003US6649376 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display
11/18/2003US6649375 Adenoviral vectors for enhanced gene expression
11/18/2003US6649374 Recombinant Chlamydia trachomatis PGP3 antigen
11/18/2003US6649373 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
11/18/2003US6649372 Which expresses heterologous nucleotide sequences; introducing expression vectors, nucleotprotein, and polymerase into a cell; allowing complex to form; culturing; use in vaccines
11/18/2003US6649371 Isolated nucleic acid molecule; using transformed cells for screening compounds for inhibiting or activating activity
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
1 ... 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 ... 2916